Journals / Acta Orthopaedica et Traumatologica Turcica / 2019 / Cilt: 53 - Sayı: 1

Histopathology of giant cell tumors of the bone: With special emphasis on fibrohistiocytic and aneurysmal bone cyst like components

Pages
35–39
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Approximately one fifth of GCTcases show recurrence and sacrum and foot bones were the most frequent sites for recurrence.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to define histopathological features of giant cell tumor of bone, especially accompanying fibrohistiocytic or aneurysmal bone cyst like components, in the light of our institutions experience.
📊
Key Findings & Data:Methods: A total of 120 cases (64 females and 56 males; mean age: 36.2 (12e80)) with ‘GCT’ diagnosed betweentheyears1996e2016wereincludedinthisretrospectiveanalysis.Caseswereevaluatedaccording to clinical features such as age, gender, localization, recurrence, metastasis and histopathological features.
💡
Conclusion & Impact:Approximately one fifth of GCTcases show recurrence and sacrum and foot bones were the most frequent sites for recurrence.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The aim of this study was to define histopathological features of giant cell tumor of bone, especially accompanying fibrohistiocytic or aneurysmal bone cyst like components, in the light of our institutions experience. Methods: A total of 120 cases (64 females and 56 males; mean age: 36.2 (12e80)) with ‘GCT’ diagnosed betweentheyears1996e2016wereincludedinthisretrospectiveanalysis.Caseswereevaluatedaccording to clinical features such as age, gender, localization, recurrence, metastasis and histopathological features. Results: Tumors were localized most frequently at proximal tibia and distal femur, respectively. In 11 cases areas rich in fibrohistiocytic component and in 20 cases aneurysmal bone cyst like component were observed. In 2 cases both components were present. Twenty three cases recurred. In 1 case which was primarily located at calcaneus, tumor metastasized to lung 4 years later during follow-up. Conclusion: GCT can be confused with other tumor or tumor-like lesions involving giant cells. Secondary changes such as fibrohistiocytic or aneurysmal bone cyst-like components and coagulation necrosis were frequently seen in conventional giant cell tumor of bone. For tumors having prominent fibrohistiocytic and/or aneurysmal bone cyst-like components, in order to detect characteristic areas representing GCT, additional sampling is essential. Although secondary histopathological changes do not appear to affect clinical outcome, these features are important in differential diagnosis. Approximately one fifth of GCTcases show recurrence and sacrum and foot bones were the most frequent sites for recurrence.

🔖

Cite This Article

ÇOMUNOĞLU, N., KEPİL, N., DERVİŞOĞLU, S. (2019). Histopathology of giant cell tumors of the bone: With special emphasis on fibrohistiocytic and aneurysmal bone cyst like components. Acta Orthopaedica et Traumatologica Turcica, Cilt: 53 - Sayı: 1, 35–39. https://ajindex.com/articles/146374

References (15)

  1. Mirra JM. Giant cell tumors. In: Mirra JM, Picci P, Gold RH, eds. Bone Tumors: Clinical, Radiologic, and Pathologic Correlations. Philadelphia: Lea & Febiger
  2. 942e1020. Unni KK, Inwards CY. Giant cell tumour (Osteoclastoma). In: Unni KK, Inwards CY, eds. Dahlin's Bone Tumors. Philadelphia: Wolters Kluwer, Lippincott Williams & Wilkins
  3. 225e242. Czerniak B. Giant cell lesions. In: Dorfman HD, Czerniak B, eds. Dorfman and Czerniak's Bone Tumors. Philadelphia: Elsevier Saunders
  4. 692e759. NiuX, Xu H, InwardsCY,et al.Primarybone tumors: epidemiologic comparison of 9200 patients treated at Beijing Ji Shui Tan Hospital, Beijing, China, with 10165 patients at Mayo clinic, Rochester, Minnesota. Arch Pathol Lab Med. 2015
  5. 1149e1155. Thomas DM, Skubitz KM. Giant cell tumour of bone. Curr Opin Oncol. 2009
  6. 338e344. Wülling M, Engels C, Jesse N, Werner M, Delling G, Kaiser E. The nature of giant cell tumor of bone. J Cancer Res Clin Oncol. 2001
  7. 467e474. Athanasou NA, Bliss E, Gatter KC, Heryet A, Woods CG, McGee JO. An immunohistological study of giant-cell tumour of bone: evidence for an osteoclast origin of the giant cells. J Pathol. 1985
  8. 153e158. Chambers TJ, Fuller K, McSheehy PM, Pringle JA. The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells. J Pathol. 1985
  9. 297e305. Zheng MH, Robbins P, Xu J, Huang L, Wood DJ, Papadimitriou JM. The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts. Histol Histopathol. 2001
  10. 297e307. Kim Y, Nizami S, Goto H, Lee FY. Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor. Clin Orthop Surg. 2012
  11. 107e116. Wülling M, Delling G, Kaiser E. The origin of the neoplastic stromal cell in giant cell tumor of bone. Hum Pathol. 2003
  12. 983e993. Goldring SR, Roelke MS, Petrison KK, Bhan AK. Human giant cell tumors of bone identification and characterization of cell types. J Clin Invest. 1987
  13. 483e491. Brecher ME, Franklin WA, Simon MA. Immunohistochemical study of mononuclear phagocyte antigens in giant cell tumor of bone. Am J Pathol. 1986
  14. 252e257. Al-Ibraheemi A, Inwards CY, Zreik RT, et al. Histologic spectrum of giant cell tumor (GCT) of bone in patients 18 Years of age and below: a study of 63 patients. Am J Surg Pathol. 2016
  15. 1702e1712. Broehm CJ, Inwards CY, Al-Ibraheemi A, et al. Giant cell tumor of bone in patients 55 Years and older: a study of